Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA.
Cleve Clin J Med. 2010 Jun;77(6):369-79. doi: 10.3949/ccjm.77a.09142.
Antithrombotic and antiplatelet drugs and percutaneous interventions have decreased the ischemic outcomes of non-ST-elevation acute coronary syndromes, but they pose risks of bleeding. The authors review the scope of the problem and ways to prevent and manage bleeding in this situation.
抗血栓和抗血小板药物以及经皮介入治疗降低了非 ST 段抬高型急性冠状动脉综合征的缺血性结局,但它们存在出血风险。作者回顾了这一问题的范围以及预防和管理这种情况下出血的方法。